Literature DB >> 4052377

Chemical trapping of complexes of dihydroxyacetone phosphate with muscle fructose-1,6-bisphosphate aldolase.

D J Kuo, I A Rose.   

Abstract

Dihydroxyacetone phosphate (DHAP) in equilibrium with FDP aldolase of muscle is present in the form of two major covalent complexes. One, representing approximately 60% of total bound substrate, decomposes to Pi and methylglyoxal upon acid denaturation of the enzyme as first reported by Grazi and Trombetta [Grazi, E., & Trombetta, G. (1979) Biochem. J. 175, 361-365]. This is now shown to be the enzyme-eneamine phosphate reaction intermediate since Pi formation is prevented if the acid denaturation is done in the presence of potassium ferricyanide, an oxidant of the eneamine. The enzyme-eneamine aldehyde X Pi 6, presumed to be an intermediate of the slow methylglyoxal synthetase reaction of aldolase, must not be a significant source of the Pi produced upon denaturation and is probably not a significant component of the equilibrium. The oxidation product, the enzyme-imine of phosphopyruvaldehyde, is sufficiently stable in 1 N HCl, t1/2 = 76 min at 0 degree C, to be isolated with the trichloroacetic acid precipitated protein. A second covalent complex, approximately 20-24% of bound dihydroxyacetone [32P]phosphate, remains with the protein during acid denaturation and centrifugation. This acid-stable complex is formed rapidly and is chased rapidly by unlabeled substrate. Its stability in 1 N HCl is similar to that of the ferricyanide-oxidized derivative mentioned above. From this and its reactivity with cyanoborohydride in acid, this complex is thought to be the imine adduct of DHAP with aldolase 4 and/or the carbinolamine complex 3 present in the initial equilibrium. D-Glyceraldehyde 3-phosphate in the carbonyl form also forms an acid-precipitable complex with aldolase.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4052377     DOI: 10.1021/bi00336a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Covalent intermediate trapped in 2-keto-3-deoxy-6- phosphogluconate (KDPG) aldolase structure at 1.95-A resolution.

Authors:  J Allard; P Grochulski; J Sygusch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Allosteric communication in mammalian muscle aldolase.

Authors:  J Sygusch; D Beaudry
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

3.  Mechanism of the Class I KDPG aldolase.

Authors:  Stephen W B Fullerton; Jennifer S Griffiths; Alexandra B Merkel; Manoj Cheriyan; Nathan J Wymer; Michael J Hutchins; Carol A Fierke; Eric J Toone; James H Naismith
Journal:  Bioorg Med Chem       Date:  2006-01-05       Impact factor: 3.641

4.  Characterization and crystal structure of Escherichia coli KDPGal aldolase.

Authors:  Matthew J Walters; Velupillai Srikannathasan; Andrew R McEwan; James H Naismith; Carol A Fierke; Eric J Toone
Journal:  Bioorg Med Chem       Date:  2007-10-18       Impact factor: 3.641

5.  Isomer activation controls stereospecificity of class I fructose-1,6-bisphosphate aldolases.

Authors:  Paul W Heron; Jurgen Sygusch
Journal:  J Biol Chem       Date:  2017-09-27       Impact factor: 5.157

6.  Effect of Solvents on Proline Modified at the Secondary Sphere: A Multivariate Exploration.

Authors:  Danilo M Lustosa; Shahar Barkai; Ido Domb; Anat Milo
Journal:  J Org Chem       Date:  2022-01-12       Impact factor: 4.198

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.